[1] Qureshi AM, Kenny D. Atrial septal defect closure in patients with pulmonary hypertension: room for punching a hole in the debate[J]. JACC Cardiovasc Interv, 2020, 13(17):2035-2037. DOI: 10.1016/j.jcin.2020.05.023.
[2] Schwerzmann M, Pfammatter JP. Approaching atrial septal defects in pulmonary hypertension[J]. Expert Rev Cardiovasc Ther, 2015, 13(6):693-701. DOI: 10.1586/14779072.2015.1047763.
[3] Balint OH, Samman A, Haberer K, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure[J]. Heart, 2008, 94(9):1189-1193. DOI: 10.1136/hrt.2006.114660.
[4] Jacobs RA, Lundby C, Robach P, et al. Red blood cell volume and the capacity for exercise at moderate to high altitude[J]. Sports Med, 2012, 42(8):643-663. DOI: 10.1007/BF03262286.
[5] Gilbert-Kawai ET, Milledge JS, Grocott MP, et al. King of the mountains: Tibetan and Sherpa physiological adaptations for life at high altitude[J]. Physiology (Bethesda), 2014, 29(6):388-402. DOI: 10.1152/physiol.00018.2014.
[6] Abdel Ghafar MA, Abdelraouf OR, Abdel-Aziem AA, et al. Pulmonary function and aerobic capacity responses to equine assisted therapy in adolescents with idiopathic scoliosis: a randomized controlled trial[J]. J Rehabil Med, 2022, 54:jrm00296. DOI: 10.2340/jrm.v54.1085.
[7] Rojas-Camayo J, Mejia CR, Callacondo D, et al. Reference values for oxygen saturation from sea level to the highest human habitation in the Andes in acclimatised persons[J]. Thorax, 2018, 73(8):776-778. DOI: 10.1136/thoraxjnl-2017-210598.
[8] World Health Organization. Iron deficiency anaemia: assessment, prevention and control: a guide for programme managers. Geneva: World Health Organization, 2001.
[9] Gonzales GF, Rubín de Celis V, Begazo J, et al. Correcting the cut-off point of hemoglobin at high altitude favors misclassification of anemia, erythrocytosis and excessive erythrocytosis[J]. Am J Hematol, 2018, 93(1):E12-E16. DOI: 10.1002/ajh.24932.
[10] Peng HT, Cheung B. A review of psychophysiological stressors on pharmacokinetics[J]. J Clin Pharmacol, 2011, 51(11):1499-1518. DOI: 10.1177/0091270010393344.
[11] Maruyama K, Harada S, Nishigori H, et al. Classification of drugs on the basis of bilirubin-displacing effect on human serum albumin[J]. Chem Pharm Bull (Tokyo), 1984, 32(6):2414-2420. DOI: 10.1248/cpb.32.2414.
[12] Pichler J, Risch L, Hefti U, et al. Glomerular filtration rate estimates decrease during high altitude expedition but increase with Lake Louise acute mountain sickness scores[J]. Acta Physiol (Oxf), 2008, 192(3):443-450. DOI: 10.1111/j.1748-1716.2007.01758.x.
[13] Sarkar MS, Desai PM. Pulmonary hypertension and cardiac anesthesia: anesthesiologist's perspective[J]. Ann Card Anaesth, 2018, 21(2):116-122. DOI: 10.4103/aca.ACA_123_17.
[14] Pritts CD, Pearl RG. Anesthesia for patients with pulmonary hypertension[J]. Curr Opin Anaesthesiol, 2010, 23(3):411-416. DOI: 10.1097/ACO.0b013e32833953fb.
[15] 盛晓艳,张清秀. 高原地区异位妊娠的诊治体会[J]. 国际医药卫生导报(学术版),2005,11(18):67-69. DOI:10.3760/cma.j.issn.1007-1245.2005.18.033.
[16] 蔡志祥,李素芝,陈普望. 高原地区先天性心脏病伴肺动脉高压手术的麻醉处理[J]. 西南军医,2010,12(5):858-859. DOI:10.3969/j.issn.1672-7193.2010.05.017.
[17] Chandhok D. Perioperative transesophageal echocardiography[J]. Mo Med, 2005, 102(5):464-468.
[18] Kratz T, Holz S, Steinfeldt T, et al. Feasibility and impact of focused intraoperative transthoracic echocardiography on management in thoracic surgery patients: an observational study[J]. J Cardiothorac Vasc Anesth, 2018, 32(2):848-852. DOI: 10.1053/j.jvca.2017.09.010.
[19] 郑玉江,董艳霞,何炼图. 经食道超声心动图对中青年偏头痛患者卵圆孔未闭的诊断及介入疗效评估[J]. 国际医药卫生导报,2022,28(3):403-405. DOI:10.3760/cma.j.issn.1007-1245.2022.03.025.
|